Bovine leukemia virus (BLV) infection of rabbits provides a safe and relatively inexpensive in vivo mammalian system for the study of the mechanisms controlling expression of a unique group of lymphotropic retroviruses. This group of viruses, which includes C-type human T-lymphotropic virus types I and II and lentiviruslike human immunodeficiency virus type 1, possesses genes coding for "trans-activating" products. Rabbits experimentally inoculated with BLV became persistently infected, as demonstrated by a number of tests. All BLV-inoculated rabbits developed persistent serum antibody to BLV. Furthermore, all BLVinoculated rabbits had peripheral blood mononuclear cells which, when stimulated, expressed the virus, as demonstrated by viral induction of syncytium formation in a BLV-susceptible fibroblast line. The presence of BLV in circulating cells was confirmed by using peripheral blood mononuclear cells from randomly selected BLV-inoculated rabbits, which showed the presence of viral reverse transcriptase activity, BLV transcriptional activity, or BLV proviral DNA. Additional tests showed that infected lymphocytes maintained in culture with recombinant human interleukin-2 formed multinucleated giant cells and produced virus when incubated in cytokine-containing medium. BLV-infected rabbits also showed alterations in several parameters associated with immunity, beginning 6 months after inoculation. Thirty-eight percent of infected rabbits developed abnormally low T-cell responses, as measured by phytolectin stimulation, and T-cell responses cycled between normal and abnormally low over a period of 20 to 24 months. Forty-four percent of rabbits infected for longer than 12 months suffered from recurrent conjunctivitis and rhinitis. By 24 months postinoculation, 28% of infected rabbits were dead or were killed because of poor clinical condition.
Cell separation. Peripheral blood mononuclear cells (PBMC) from BLV-inoculated and control rabbits were separated from heparinized whole blood by Ficoll-Hypaque sedimentation (density, 1.09 g/ml) as described before (40 ELISA. An enzyme-linked immunosorbent assay (ELISA) was performed on purified BLV as described previously (4) . The color reaction between peroxidase and 5-aminosalicylate was allowed to proceed for 2 h, after which color intensity was evaluated at 570 nm with an ELISA plate reader (Cambridge Technology, Cambridge, Mass.). Antibody titer was defined as the reciprocal of the serum dilution which gave color intensity twice that of either a preinoculation serum sample from the same rabbit or serum from a control rabbit at the same dilution.
Syncytium formation assay. PBMC from BLV-inoculated rabbits were suspended at 4 x 106 cells per ml of RPMI 1640 containing 10 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) and antibiotics (RPMI) with 5% normal rabbit serum and incubated with 2.5 mg of phytohemagglutinin-L (PHA-L; Sigma Chemical Co., St. Louis, Mo.) per ml for 48 h at 37°C in 5% CO2. The PBMC were then washed and resuspended in RPMI. The suspension was divided into two equal portions. Each portion was made 10% serum with either anti-BLV bovine serum or normal bovine serum and placed on a monolayer of bat lung fibroblasts (TblLu; Wistar Institute), a cell line that is free of bovine syncytial virus and parainfluenza virus type 3 and is not susceptible to infection by bovine herpesvirus type 1 or bovine viral diarrhea virus (American Type Culture Collection). After 18 h at 37°C and 5% C02, the PBMC were removed, and the monolayers were washed in Dulbecco modified Eagle medium containing 10 mM HEPES and antibiotics (DMEM) and incubated overnight in DMEM containing 10% fetal bovine serum (FBS) . Monolayers were maintained in growth phase for 4 to 5 days, and then 5 x 105 cells were placed in a 25-cm2 flask and incubated for an additional 1 to 2 days. The relative numbers of syncytia (defined as cells containing five or more nuclei [9] ) were determined by counting the syncytia present in 20 consecutive fields with an inverted microscope at a magnification of 10Ox. Backgrounds were subtracted, and results are expressed as number of syncytia per square centimeter. Controls consisted of identically treated PBMC from 10 different control rabbits.
RT assay. Clarified supernatants from 1 x 107 to 2 x 107 PBMC stimulated with PHA-L for 48 to 72 h were centrifuged at 90,000 x g for 1 h at 4°C, and the resulting pellets were suspended in 160 ml of 0.1 M Tris, pH 7.8. Reverse transcriptase (RT) activity was determined in triplicate 50-,ul samples in the presence of magnesium by an assay modified for BLV (16, 19) . Activity is expressed as picomoles per hour per 108 cells. Negative controls consisted of identically obtained supernatants from 1 x 107 to 2 x 107 control rabbit PBMC. Positive controls were clarified, ultracentrifuged virus pellets from supernatants of BLV-FLK cells.
Northern (RNA) blot analysis. Blood was drawn from three BLV-inoculated rabbits, and PBMC were isolated as described before (40) . Because only a limited amount of blood could be drawn from each infected rabbit at a given time, the PBMC were pooled to obtain sufficient RNA to analyze. RNA was isolated from PBMC of BLV-inoculated and control rabbits and a BLV-infected cow by CsCl gradient centrifugation as described before (7) . Denaturing formaldehyde gels were run on a total RNA from PBMC which had been stimulated for 24 to (31) . Second, PBMC from all BLVinoculated rabbits were assayed for virus expression by the development of syncytia on BLV-sensitive fibroblasts. Cocultivation of BLV-susceptible fibroblasts with lymphocytes from BLV-infected cattle has been used to detect the production of BLV by lymphoid cells (12) . The syncytia assay had two functions. It confirmed that the rabbits were infected with BLV, because TblLu is susceptible to BLV but is not susceptible to several other common bovine pathogens (see description in Materials and Methods). Additionally, it served as a means to demonstrate recovery of BLV from circulating cells of inoculated animals, because BLV-induced cell fusion is the cytopathic effect seen in TblLu (9, 19) . Additional confirmation of the presence of BLV in inoculated rabbit cells was achieved through evaluation of PBMC from randomly selected animals for viral RT activity, presence of viral mRNA by Northern blot analysis, or presence of provirus as detected by PCR (33) . All BLVinoculated rabbits were monitored for clinical signs suggestive of suppressed immune function. A summary of the results of the tests is shown in Table 1 .
Antibody response to BLV. To confirm and extend earlier reports of persistent anti-BLV antibodies in rabbits (6), 18 New Zealand White rabbits were inoculated with BLV. Sera were collected from these rabbits over a period of 18 months and analyzed by ELISA. For animals which survived longer than 18 months, samples were collected up to 24 months postinoculation. Table 2 shows four separate examples of antibody titer patterns observed in BLV-inoculated rabbits tested repeatedly over 24 months postinoculation. Titers varied considerably with time, in some cases falling to undetectable levels and then becoming detectable again later in the infection. Although no consistent pattern of rising and falling anti-BLV titers was observed, each rabbit produced antibody over an extended period of time. In Table 3 , the ranges of anti-BLV antibody titers are shown for all BLVinoculated rabbits for early (2 to 3 months), middle (6 to 8 months), and late (12 to 18 months) time points after inoculation. All of the BLV-inoculated animals produced anti-BLV antibodies for prolonged periods postinoculation. None of the rabbits which received inocula other than BLV developed detectable levels of anti-BLV antibody.
Syncytium formation in BLV-susceptible indicator fibroblasts and inhibition with anti-BLV antibody. In order to further demonstrate that BLV-inoculated rabbits had become persistently infected and to recover BLV from circulating PBMC, we evaluated the ability of phytolectin-stimulated PBMC from BLV-inoculated rabbits to produce syncytia upon cocultivation with susceptible bat lung fibroblasts (TblLu). (12) 100 (4)-10,000 (1) 100 (7)-10,000 (1) 100 (5)-6,000 (1)b BLV-FLK (4) 100 (1-1,000 (3) 100 (2)-1,000 (2) BDC (2)-250 (1) Cell-free BLV (2) 10,000 (2) 10,000 (2) 10,000 (2) Uninfected lymphocytes (2) BD (2) BD (2) BD (2) a Titers were determined by ELISA; sera from rabbits receiving no BLV gave no detectable titers. b Animal which had titer of 10,000 was dead at 12 months. c BD, Below detection limit.
per cm2) when PBMC from BLV-inoculated rabbits were incubated in normal bovine serum. Second, syncytium formation was always decreased (2.7-to >25-fold) when PBMC from BLV-inoculated rabbits were incubated with anti-BLV serum. None of 10 age-matched control rabbits tested at the same time had PBMC which induced syncytium formation above background. The formation of syncytia in the presence of BLV-inoculated rabbit cells and the inhibition of syncytium formation in the presence of anti-BLV antiserum provided further evidence that cells from BLV-inoculated rabbits were indeed persistently infected with the virus.
RT activity. The presence of RT activity in virus-infected cells has often been used as an indicator of retrovirus infection. To assess whether RT activity could be detected in BLV-inoculated rabbits, PBMC from a number of animals were tested. Culture supernatants from phytolectin-activated PBMC from control and BLV-inoculated rabbits were assayed for RT activity in an assay mix containing magnesium and modified to measure BLV RT (9, 16) . Whereas no RT activity above background was detected in samples from seven uninfected rabbits, samples from 4 of 10 BLV-inoculated rabbits sampled between 6 and 20 months postinoculation exhibited appreciable RT activity (16.4 + 8.0 pmol/h per 108 cells) (data not shown). Detectable RT activity in BLV-inoculated animals strongly suggests that circulating PBMC from such animals are infected with the virus.
Northern blot analysis. Like HTLV-I, BLV is not produced at detectable levels in freshly isolated lymphocytes of the infected host but is often expressed when those cells are cultured in vitro (11, 14, 23, 24, 28) . To determine whether BLV transcripts could be detected in infected rabbit PBMC, Northern blot analyses with a BLV cDNA probe were performed on total RNA obtained from phytolectin-stimulated PBMC from several of the BLV-inoculated rabbits. Figure 1 shows an experiment in which RNA was isolated and pooled from a limited amount of blood from three BLV-inoculated rabbits and compared with RNA obtained from PBMC from an uninfected rabbit and from a BLVinfected cow. BLV transcripts were detected in RNA from the BLV-inoculated rabbits and the BLV-infected cow but not in the control rabbit RNA. Different hybridizing mRNA species were observed in the infected-rabbit mRNA population and might be the result of alternative splicing events.
PCR. PCR analysis was also performed to determine whether proviral DNA could be detected in cells from BLV-infected rabbits. In HTLV-I-and HIV-1-infected humans, only a small percentage of lymphocytes can be demonstrated to contain proviral DNA (34) . We suspected a similar situation might exist in cells from BLV-infected rabbits because of the difficulty we encountered in demonstrating RT activity and BLV transcripts. In order to detect such rare events, an extremely sensitive method such as the PCR assay (33) is required. As shown in Fig. 2 , BLV sequences could be detected in one of two rabbits inoculated with BLV 12 months previously but could not be found in the DNA from the control rabbit. The rabbit with the positive PCR was not one of the three rabbits from which pooled RNA was taken for Northern blot analysis (Fig. 1) . These data indicate that BLV provirus can be demonstrated in circulating PBMC from at least some BLV-infected rabbits.
Multinucleated-cell formation in long-term rabbit PBMC infected rabbits had altered growth characteristics in longterm culture, PBMC from BLV-infected and control rabbits were stimulated with phytolectin and maintained in culture with human recombinant IL-2. During the first 20 to 30 days of culture, major differences were observed in the growth of infected-rabbit PBMC compared with PBMC from normal animals. Specifically, beginning at 4 to 5 days of culture, giant multinucleated cells formed in cultures initiated from BLV-infected rabbits (Fig. 3) . In some of the giant cells, as many as 25 to 30 nuclei were observed. Figure 4 shows growth patterns during the first 28 days in culture of PBMC from a normal rabbit and PBMC from a BLV-infected rabbit: During that period, while giant cells formed in the infected- PBMC cultures, total cell numbers did not increase. IL-2-dependent cell proliferation could be detected in BLVinfected cultures only after giant-cell formation ceased (by 30 BLV could be produced by lymphocytes from infected rabbits, IL-2-dependent lymphocyte cultures were derived from PBMC of infected rabbits. BLV expression was induced from lymphocytes maintained in long-term culture for 3 months or longer by adding cytokine-containing supernatants from phytolectin-stimulated PBMC from uninfected rabbits to the long-term cultures of IL-2-dependent lymphocytes derived from BLV-infected rabbits. Virus expression was monitored by induction of syncytium formation on susceptible fibroblasts (TblLu) ( Table 5 ). In three separate experiments, lymphocytes from three different BLVinfected rabbits induced increased numbers of syncytia in the presence of supernatant compared with the numbers seen either in the absence of supernatant, in the presence of anti-BLV antiserum, or in comparison with cells from an uninfected rabbit.
Response of peripheral blood leukocytes to phytolectin stimulation. To assess whether BLV infection was affecting rabbit T-lymphocyte function, a method which measures general responsiveness of T lymphocytes was used. Circulating leukocytes from the first 11 rabbits to receive BLVinfected bovine lymphocytes and the first two rabbits to receive BLV-FLK cells were evaluated at regular intervals for response to stimulation by the T-lymphocyte-stimulatory phytolectins PHA and ConA. The stimulation obtained with BLV-inoculated rabbit leukocytes was compared with the stimulation obtained with age-matched control rabbit leukocytes run at the same time. The BLV-inoculated rabbits were evaluated for 18 to 24 months or until they died. The data (Fig. 5) revealed that leukocyte responses to phytolectin stimulation fluctuated in an abnormal and apparently random manner which was different for each BLV-infected rabbit.
Specifically, analysis of the data after 6 months showed that responses of five animals had become abnormally low, five had remained normal, and three had become elevated. ]thymidine into PHA-stimulated control rabbit leukocytes ranged between 20,000 and 45,000 cpm for control rabbits less than 18 months old and between 6,000 and 15,000 cpm for control rabbits over 18 months old. Unstimulated leukocytes incorporated between 100 and 700 cpm regardless of the age of the animal.
animal was killed (see Pathology). At 20 months postinoculation, the two rabbits which had developed abnormally high responses within 6 to 14 months postinoculation were found dead (see Pathology). The remaining two rabbits have responses within the normal range at this time. The three animals with responses above normal within the first 6 months still have abnormally high responses after 19 to 20 months (148, 225, and 286% of normal). Together, these data show that most BLV-infected rabbits develop unique and abnormal patterns of T-lymphocyte responsiveness.
Pathology. Within 12 to 18 months of inoculation, three rabbits displayed marked weight loss (one of these rabbits, no. 5, was euthanized). In six additional rabbits, there were clinical indications of upper respiratory disease. The clinical indications of upper respiratory disease most often found were conjunctival and nasal exudates. The extent of weight loss in one of the BLV-infected rabbits is shown in Fig. 6 Gross and histological examination of these five rabbits revealed inflammatory processes of the colon in two rabbits (nos. 1 and 2). Rabbit 1 exhibited a moderate plasmacytic and lymphocytic colitis, and rabbit 2 had a focal chronic transmural colitis. The colonic lesion of rabbit 2 was associated with a focal perforation. Although we hypothesized that a foreign body might have caused the perforation, a foreign body was not found. Inflammatory changes of the epicardium, pulmonary pleura, kidney, and liver were found in rabbits 3 and 4. Rabbit 3 exhibited a fibrinous and suppurative pleuritis and pericarditis, and rabbit 4 had moderate interstitial lymphocytic nephritis and periportal lymphocytic hepatitis. Pasteurella multocida was isolated from the pericardial and pleural lesions; however, the cause of the hepatic and renal inflammation was not determined. Rabbit 5, the last one necropsied, had only a moderate increased cellularity of peribronchial lymphoid tissue.
The gross and histological examinations of rabbits 2 and 3 revealed processes of adequate severity to explain the clinical course in these BLV-infected rabbits. Furthermore, the pleural and pericardial lesions caused by P. multocida in rabbit 4 certainly contributed to the death of this rabbit; however, the reason for the proliferation of this common rabbit pathogen in this rabbit was (30, 37, 41, 42) . The presence of such cells suggests that BLV expression induced by stimulating infected cells resulted in their subsequent fusion. Preliminary results indicate the presence of intensely stained nonspecific esterasepositive cells in the fusions, suggesting that some monocytes might be infected with the virus. Studies are in progress to evaluate BLV expression in these fused cells.
Furthermore, once fusion has ceased and IL-2-dependent growth has become established, a portion of the remaining lymphocytes must carry the virus. Our data show that BLV expression can be induced from cultured long-term IL-2-dependent lymphocytes when those lymphocytes are incubated with a cytokine-containing medium derived from PBMC of control rabbits. IL-2 does not appear to be sufficient to induce virus expression, because cultures containing IL-2 without cytokine-containing medium did not induce syncytium formation. Our results are similar to those reported for induction of HIV-1 from a monocyte cell line by cytokine-containing medium (13) in that long-term-cultured, infected cells require cytokine stimulation in order to express virus. These findings are important because they indicate that both monocytes and lymphocytes can be reservoirs of BLV in infected rabbits.
While all BLV-inoculated rabbits showed persistent BLV infection, the confirming tests for BLV (RT assay, Northern blot analysis, and PCR) done on PBMC did not show the presence of virus in all animals tested. It is interesting that RT activity was detected in cells from animals that had been infected for longer than 1 year and were showing signs of disease. Two animals which were RT negative at 6 months postinoculation were RT positive over 1 year later, suggesting that too few infected cells were present in those rabbits early in the infection to produce enough virus to detect in this assay. Failure to consistently detect BLV message by Northern blot analysis and BLV proviral sequences by PCR could also be due to the presence of very few infected cells in the preparations from which the nucleic acids were extracted. The presence of very few circulating infected cells has been a typical observation by other investigators studying lymphotropic retroviruses. For example, although sheep are very sensitive to infection with BLV (22) , BLV-infected sheep have been estimated to have between 1 in 2 x 103 and 1 in 5 x 105 infected circulating cells early in infection (25) . Similarly, HIV-1-infected people have fewer than 1 in 104 infected circulating lymphocytes (20, 34) . These findings are consistent with our observations. Recently, attention has been given to the presence of an additional bovine retrovirus, which has been classified as a lentivirus. Tentatively named bovine immunodeficiencylike virus, or BIV (18), it was isolated from some cattle with persistent lymphocytosis, wasting, and central nervous system signs (39) . While BIV infection does not appear to be widespread among cattle in the United States (M. A. Gonda, 10th Annu. W. Food Anim. Dis. Res. Conf., 1989, abstr.), it is of concern that some of our rabbits, notably those that received lymphocytes from a BLV-seropositive, persistently lymphocytotic cow, could have received a mixed BLV-BIV infection. While we know that all of our rabbits became infected with BLV, we do not believe that the changes observed in our rabbits were the result of a superimposed BIV lentivirus infection. BLV-infected rabbits developed clinical signs of disease whether the animals were given homogeneous BLV preparations (BLV-FLK cells or purified BLV) or bovine lymphocytes. In fact, homogeneous BLV preparations appeared to be more effective in inducing disease signs in rabbits (six of six rabbits with clinical signs) than were bovine lymphocyte suspensions (6 of 12 rabbits with clinical signs) ( We have demonstrated that BLV infects rabbits, and we suggest that this viral infection can result in immune dysfunction which may predispose infected animals to secondary infections and death. Because BLV is one of a unique group of trans-acting lymphotropic retroviruses, the use of BLV infection in rabbits provides a safe and relatively inexpensive in vivo system for studies of expression of viruses which contain trans-acting genes.
